ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. It is also developing ReWalk Restore, a soft suit exoskeleton for individuals who have suffered a stroke. ReWalk Robotics Ltd. markets and sells its products directly to third party payers, institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokne'am Illit, Israel.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Phone972-4959-0123
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$6.55 million
Profitability
Miscellaneous
Employees58
Next Earnings Date8/13/2019 (Estimated)
OptionableNot Optionable
Rewalk Robotics (NASDAQ:RWLK) Frequently Asked Questions
What is Rewalk Robotics' stock symbol?
Rewalk Robotics trades on the NASDAQ under the ticker symbol "RWLK."
How were Rewalk Robotics' earnings last quarter?
Rewalk Robotics Ltd (NASDAQ:RWLK) released its quarterly earnings data on Tuesday, May, 7th. The medical device company reported ($1.25) earnings per share for the quarter, missing the Zacks' consensus estimate of ($1.00) by $0.25. The medical device company earned $1.58 million during the quarter, compared to the consensus estimate of $1.62 million. View Rewalk Robotics' Earnings History.
When is Rewalk Robotics' next earnings date?
What price target have analysts set for RWLK?
2 Wall Street analysts have issued 12-month price objectives for Rewalk Robotics' shares. Their forecasts range from $2.00 to $2.00. On average, they expect Rewalk Robotics' share price to reach $2.00 in the next year. This suggests that the stock has a possible downside of 30.6%. View Analyst Price Targets for Rewalk Robotics.
What is the consensus analysts' recommendation for Rewalk Robotics?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rewalk Robotics in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Rewalk Robotics.
Has Rewalk Robotics been receiving favorable news coverage?
News stories about RWLK stock have trended negative recently, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Rewalk Robotics earned a news sentiment score of -2.7 on InfoTrie's scale. They also gave news stories about the medical device company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the company's share price in the next few days.
Who are some of Rewalk Robotics' key competitors?
What other stocks do shareholders of Rewalk Robotics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Rewalk Robotics investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet Specialty Products Partners, L.P (CLMT), Two Harbors Investment (TWO), Novocure (NVCR), Blackrock Capital Investment (BKCC), Viper Energy Partners (VNOM), Summit Midstream Partners (SMLP), Washington Prime Group (WPG) and Park Sterling (PSTB).
Who are Rewalk Robotics' key executives?
Rewalk Robotics' management team includes the folowing people:
- Mr. Lawrence J. Jasinski, CEO & Director (Age 62)
- Mr. Ori Gon, Chief Financial Officer (Age 38)
- Ms. Miri Pariente, VP of QA & Operations (Age 42)
- Mr. Loren Wass, VP of Sales & Reimbursement
- Mr. Andy Dolan, VP of Marketing
Who are Rewalk Robotics' major shareholders?
Rewalk Robotics' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Sabby Management LLC (31.25%) and Advisor Group Inc. (14.54%). Company insiders that own Rewalk Robotics stock include Jeff Dykan, Jodi Gricci, Lawrence J Jasinski, Scp Vitalife Partners (Israel), Scp Vitalife Partners Ii Lp and Wayne Weisman. View Institutional Ownership Trends for Rewalk Robotics.
Which major investors are selling Rewalk Robotics stock?
Which major investors are buying Rewalk Robotics stock?
How do I buy shares of Rewalk Robotics?
Shares of RWLK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Rewalk Robotics' stock price today?
One share of RWLK stock can currently be purchased for approximately $2.88.
How big of a company is Rewalk Robotics?
Rewalk Robotics has a market capitalization of $13.01 million and generates $6.55 million in revenue each year. The medical device company earns $-21,670,000.00 in net income (profit) each year or ($14.75) on an earnings per share basis. Rewalk Robotics employs 58 workers across the globe.
What is Rewalk Robotics' official website?
How can I contact Rewalk Robotics?
Rewalk Robotics' mailing address is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. The medical device company can be reached via phone at 972-4959-0123 or via email at [email protected]
MarketBeat Community Rating for Rewalk Robotics (NASDAQ RWLK)
MarketBeat's community ratings are surveys of what our community members think about Rewalk Robotics and other stocks. Vote "Outperform" if you believe RWLK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RWLK will underperform the S&P 500 over the long term. You may vote once every thirty days.
